The Science
BioCair Technology
BC-65 is a patented formulation with a proven mechanism of action against the broadest spectrum of healthcare pathogens, independently verified at UK UKAS-accredited laboratories.
99.999%
Pathogen Elimination
<60s
Aerial Kill Time
9+
Pathogen Types Covered
EN17272
European Certified
How It Works
Three-stage pathogen elimination
Aerosolisation
BioCair BC-65 solution is converted into ultra-fine dry-mist particles (<10 µm) and released into the room atmosphere via the RADS system.
Membrane Disruption
The active compound penetrates the plasma membrane lipid bilayer of pathogens, irreversibly disrupting cellular integrity and metabolic function.
Kill Confirmed
99.999% (5-log) reduction in aerial pathogens achieved in under 60 seconds. Surface pathogens eliminated within minutes, verified by UK-accredited laboratory testing.
In Action
See BioCair at work
BioCair RADS in operation across healthcare environments, demonstrating speed, coverage, and non-disruptive deployment.
Pathogen Coverage
One solution. Comprehensive spectrum.
BioCair BC-65 has been independently tested against the pathogens of greatest clinical concern in UK healthcare. Testing conducted at AFNSC and UK UKAS-accredited laboratories to European standard test protocols.
Pathogen
Test Standard
Safety Profile
Designed for occupied healthcare environments
Non-Toxic
Safe for healthcare environments. No hazardous residue after treatment.
Non-Corrosive
Compatible with medical equipment, electronics, and sensitive surfaces.
pH Neutral
No damage to sensitive equipment or surfaces. No staff health risk from residue.
Alcohol-Free
No fire hazard. Suitable for continuous or occupied-space deployment.
Get in touch
Enquire about BioCair RADS for your facility
Speak with our team about product demonstration and service contracts.